Ruxolitinib cream monotherapy for facial and/or neck atopic dermatitis: results from a decentralized, randomized phase 2 clinical trial
Ruxolitinib cream improved signs and symptoms of facial/neck AD vs vehicle and was well tolerated.
Authors
- Jonathan Cotliar
- Zhihong Lai (ORCID: https://orcid.org/0000-0001-6475-4360)
- Zelma C. Chiesa Fuxench (ORCID: https://orcid.org/0000-0003-0023-4176)
- Haq Nawaz (ORCID: https://orcid.org/0000-0001-8888-4733)
- YuTzu Kuo
Institutions
- University of Pennsylvania (US)
- Incyte (United States) (US)
Publication Details
- Journal
- Journal of Dermatological Treatment
- Published
- 2025-03-25
- DOI
- https://doi.org/10.1080/09546634.2025.2480744
- Citations
- 3
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 6.01